RPS21 Enhances hepatocellular carcinoma development through GPX4 stabilization
Siyuan Wu1, Gaochao Wang1, Likai Gu1
1Nanjing Medical University, Nanjing, 211166, China; The Department of Hepato-biliary-pancreatic Surgery, The Institute of Hepatobiliary and Pancreatic Diseases, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China.
Translational Oncology
|November 15, 2024
Summary
The gene RPS21 promotes liver cancer (hepatocellular carcinoma) by increasing tumor aggressiveness and affecting cell growth. Targeting RPS21 offers a potential new therapy for liver cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern with limited effective therapies.
- Understanding the molecular drivers of HCC progression is crucial for developing targeted treatments.
- The role of ribosomal protein S21 (RPS21) in HCC pathogenesis remains largely unexplored.
Purpose of the Study:
- To investigate the oncogenic role of RPS21 in hepatocellular carcinoma.
- To explore the correlation between RPS21 expression and HCC patient prognosis.
- To elucidate the underlying mechanisms by which RPS21 influences HCC progression and oxidative stress.
Main Methods:
- Bioinformatic analysis of The Cancer Genome Atlas (TCGA) database and clinical samples.
- Kaplan-Meier survival analysis and mutation analysis using cBioPortal.
- Experimental validation using cell culture (lentiviral knockdown/overexpression) and mouse models.
- Mechanistic studies involving ubiquitination and stability assays of GPX4.
Main Results:
- RPS21 is significantly upregulated in HCC tissues and associated with advanced clinical stages and poorer patient survival (OS, PFS, RFS, DSS).
- RPS21 amplification is linked to unfavorable prognosis in HCC.
- RPS21 knockdown inhibits HCC cell proliferation and migration, while overexpression enhances these processes.
- RPS21 modulates GPX4 stability, impacting ferroptosis and oxidative stress in HCC cells.
Conclusions:
- RPS21 functions as an oncogene in hepatocellular carcinoma.
- RPS21 expression levels and genetic alterations are significant prognostic markers for HCC.
- Targeting RPS21 presents a promising therapeutic strategy for hepatocellular carcinoma.
- RPS21's role in regulating oxidative stress and ferroptosis provides new insights into HCC treatment.
Related Concept Videos
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


